BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nuryadi E, Sasaki Y, Hagiwara Y, Permata TBM, Sato H, Komatsu S, Yoshimoto Y, Murata K, Ando K, Kubo N, Okonogi N, Takakusagi Y, Adachi A, Iwanaga M, Tsuchida K, Tamaki T, Noda SE, Hirota Y, Shibata A, Ohno T, Tokino T, Oike T, Nakano T. Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy. Oncotarget 2018;9:32642-52. [PMID: 30220971 DOI: 10.18632/oncotarget.25982] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Dutta P, Basu M, Roy A, Mandal RK, Panda CK. High nuclear expression of DNMT1 in correlation with inactivation of TET1 portray worst prognosis among the cervical carcinoma patients: clinical implications. J Mol Histol 2023. [PMID: 36692670 DOI: 10.1007/s10735-023-10114-z] [Reference Citation Analysis]
2 Oike T, Sekiguchi Y, Yoshimoto Y, Oike T, Ando K, Gu W, Sasaki Y, Tokino T, Iwase A, Ohno T. Mutation Analysis of Radioresistant Early-Stage Cervical Cancer. IJMS 2021;23:51. [DOI: 10.3390/ijms23010051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Azimzadeh O, Gomolka M, Birschwilks M, Saigusa S, Grosche B, Moertl S. Advanced Omics and Radiobiological Tissue Archives: The Future in the Past. Applied Sciences 2021;11:11108. [DOI: 10.3390/app112311108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Dariya B, Nagaraju GP. Resistance to chemotherapy among ethnic and racial groups: Health disparities perspective in gynecologic cancers. Overcoming Drug Resistance in Gynecologic Cancers 2021. [DOI: 10.1016/b978-0-12-824299-5.00016-2] [Reference Citation Analysis]
5 Adiga D, Eswaran S, Pandey D, Sharan K, Kabekkodu SP. Molecular landscape of recurrent cervical cancer. Crit Rev Oncol Hematol 2021;157:103178. [PMID: 33279812 DOI: 10.1016/j.critrevonc.2020.103178] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
6 Yoshimoto Y, Sasaki Y, Murata K, Noda SE, Miyasaka Y, Hamamoto J, Furuya M, Hirato J, Suzuki Y, Ohno T, Tokino T, Oike T, Nakano T. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy. Gynecol Oncol 2020;159:546-53. [PMID: 32951893 DOI: 10.1016/j.ygyno.2020.08.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Gondhowiardjo SA, Handoko, Jayalie VF, Apriantoni R, Barata AR, Senoaji F, Utami IJW, Maubere F, Nuryadi E, Giselvania A. Tackling Resistance to Cancer Immunotherapy: What Do We Know? Molecules 2020;25:E4096. [PMID: 32911646 DOI: 10.3390/molecules25184096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Oike T, Komatsu S, Komatsu Y, Nachankar A, Darwis NDM, Shibata A, Ohno T. Reporting of methodologies used for clonogenic assays to determine radiosensitivity. J Radiat Res 2020;61:828-31. [PMID: 32823284 DOI: 10.1093/jrr/rraa064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ohno T. Heavy Ion Biological Research at the Department of Radiation Oncology in Gunma University. kmj 2020;70:273-275. [DOI: 10.2974/kmj.70.273] [Reference Citation Analysis]
10 Darwis NDM, Nachankar A, Sasaki Y, Matsui T, Noda SE, Murata K, Tamaki T, Ando K, Okonogi N, Shiba S, Irie D, Kaminuma T, Kumazawa T, Anakura M, Yamashita S, Hirakawa T, Kakoti S, Hirota Y, Tokino T, Iwase A, Ohno T, Shibata A, Oike T, Nakano T. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy. Int J Mol Sci 2019;20:E4563. [PMID: 31540114 DOI: 10.3390/ijms20184563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
11 Kumar R, Paul AM, Rameshwar P, Pillai MR. Epigenetic Dysregulation at the Crossroad of Women's Cancer. Cancers (Basel) 2019;11:E1193. [PMID: 31426393 DOI: 10.3390/cancers11081193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
12 Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells 2019;8:E622. [PMID: 31234354 DOI: 10.3390/cells8060622] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 24.8] [Reference Citation Analysis]
13 Tong J, Yu H, Li J, Zhou J, Ma X, Yang J. Short-term recurrence and distant metastasis following robotic-assisted radical hysterectomy with pelvic lymphadenectomy and chemoradiotherapy for a stage IB1 cervical adenocarcinoma: A case report and literature review. Medicine (Baltimore) 2019;98:e15387. [PMID: 31027131 DOI: 10.1097/MD.0000000000015387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]